Treatment
Table 6. Pharmacologic Recommendations for the Initial
Management of Hip Osteoarthritis (OA)
a
The ACR conditionally recommends that patients with hip OA should use one of the
following:
• Acetaminophen • Tramadol
• Oral NSAIDs • Intraarticular corticosteroid injections
The ACR conditionally recommends that patients with hip OA should NOT use
the following:
• Chondroitin sulfate • Glucosamine
The ACR has no recommendation regarding the use of the following:
• Topical NSAIDs
• Intraarticular hyaluronate injections
• Duloxetine
• Opioid analgesics
a
No strong recommendations were made for the initial pharmacologic management of hip OA.
Table 5. Nonpharmacologic Recommendations for the
Management of Hip Osteoarthritis (OA)
The ACR strongly recommends that patients with hip OA should do the following:
• Participate in cardiovascular (aerobic) and/or resistance land-based exercise
• Participate in aquatic exercise
• Lose weight (for persons who are overweight)
The ACR conditionally recommends that patients with hip OA should do the
following:
• Participate in self-management programs
• Receive manual therapy in combination with supervised exercise
• Receive psychosocial interventions
• Be instructed in the use of thermal agents
• Receive walking aids, as needed
The ACR has no recommendations regarding the following:
• Participation in balance exercises, either alone or in combination with strengthening
exercises
• Participation in tai chi
• Receiving manual therapy alone
Hip
